Kenvue Inc. (NYSE:KVUE) Shares Sold by South Dakota Investment Council

South Dakota Investment Council lessened its stake in Kenvue Inc. (NYSE:KVUE) by 17.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 335,366 shares of the company’s stock after selling 69,565 shares during the period. South Dakota Investment Council’s holdings in Kenvue were worth $7,160,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of KVUE. Howard Capital Management Inc. boosted its stake in shares of Kenvue by 5.5% during the fourth quarter. Howard Capital Management Inc. now owns 11,697 shares of the company’s stock worth $250,000 after buying an additional 607 shares during the period. TCW Group Inc. raised its holdings in Kenvue by 2.6% during the fourth quarter. TCW Group Inc. now owns 24,328 shares of the company’s stock worth $519,000 after purchasing an additional 621 shares in the last quarter. First Horizon Advisors Inc. raised its holdings in Kenvue by 2.4% during the fourth quarter. First Horizon Advisors Inc. now owns 25,047 shares of the company’s stock worth $535,000 after purchasing an additional 580 shares in the last quarter. Sigma Planning Corp raised its holdings in Kenvue by 2.5% during the fourth quarter. Sigma Planning Corp now owns 39,641 shares of the company’s stock worth $846,000 after purchasing an additional 955 shares in the last quarter. Finally, SAM Advisors LLC raised its holdings in Kenvue by 8.0% during the fourth quarter. SAM Advisors LLC now owns 56,676 shares of the company’s stock worth $1,210,000 after purchasing an additional 4,217 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Citigroup cut their price target on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating for the company in a report on Wednesday, January 15th. UBS Group cut their price target on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, February 7th. Royal Bank of Canada reissued a “sector perform” rating and set a $24.00 price target on shares of Kenvue in a report on Monday, February 3rd. Canaccord Genuity Group dropped their target price on shares of Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a report on Friday, February 7th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Kenvue from a “buy” rating to a “hold” rating and dropped their target price for the company from $25.00 to $24.00 in a report on Thursday, December 12th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $23.00.

Kenvue Stock Up 4.1 %

Shares of NYSE KVUE opened at $23.31 on Friday. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The firm’s 50 day moving average price is $21.31 and its 200 day moving average price is $22.18. The firm has a market cap of $44.68 billion, a P/E ratio of 43.97, a price-to-earnings-growth ratio of 2.62 and a beta of 1.45. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be issued a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, February 12th. This represents a $0.82 annualized dividend and a dividend yield of 3.52%. Kenvue’s payout ratio is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.